Ten years of anti-vascular endothelial growth factor therapy von Ferrara, Napoleone, Adamis, Anthony P.

Volltext

Sustained Benefits from Ranibizumab for Macular Edema Following Branch Retinal Vein Occlusion: 12-Month Outcomes of a Phase III Study von Brown, David M., MD, FACS, Campochiaro, Peter A., MD, Bhisitkul, Robert B., MD, Ho, Allen C., MD, Gray, Sarah, PhD, Saroj, Namrata, OD, Adamis, Anthony P., MD, Rubio, Roman G., MD, Murahashi, Wendy Yee, MD

Volltext

Immunological mechanisms in the pathogenesis of diabetic retinopathy von Adamis, Anthony P., Berman, Adrienne J.

Volltext

Feasibility demonstration of a device for vitreous liquid biopsy incidental to intravitreal injection von Tumlinson, Alexandre R, Calara, Jennifer M, Azar, Dimitri T, Adamis, Anthony P, Vavvas, Demetrios G, Stewart, Jay M

Volltext

Vascular Endothelial Growth Factor-A Is a Survival Factor for Retinal Neurons and a Critical Neuroprotectant during the Adaptive Response to Ischemic Injury von Nishijima, Kazuaki, Ng, Yin-Shan, Zhong, Lichun, Bradley, John, Schubert, William, Jo, Nobuo, Akita, Jo, Samuelsson, Steven J, Robinson, Gregory S, Adamis, Anthony P, Shima, David T

Volltext

Age-Related Macular Degeneration: Etiology, Pathogenesis, and Therapeutic Strategies von Ambati, Jayakrishna, Ambati, Balamurali K, Yoo, Sonia H, Ianchulev, Sean, Adamis, Anthony P

Volltext

Inhibition of Platelet-Derived Growth Factor B Signaling Enhances the Efficacy of Anti-Vascular Endothelial Growth Factor Therapy in Multiple Models of Ocular Neovascularization von Jo, Nobuo, Mailhos, Carolina, Ju, Meihua, Cheung, Eunice, Bradley, John, Nishijima, Kazuaki, Robinson, Gregory S., Adamis, Anthony P., Shima, David T.

Volltext

Nonsteroidal anti‐inflammatory drugs prevent early diabetic retinopathy via TNF‐α suppression von M. Joussen, Antonia, Poulaki, Vassiliki, Mitsiades, Nicholas, Kirchhof, Bernd, Koizumi, Kan, Döhmen, Sven, P. Adamis, Anthony

Volltext

Leukocyte-Mediated Endothelial Cell Injury and Death in the Diabetic Retina von Joussen, Antonia M., Murata, Toshinori, Tsujikawa, Akitaka, Kirchhof, Bernd, Bursell, Sven-Erik, Adamis, Anthony P.

Volltext

Anti-VEGF Aptamer (Pegaptanib) Therapy for Ocular Vascular Diseases von NG, EUGENE W.M., ADAMIS, ANTHONY P.

Volltext

Retinal Vascular Endothelial Growth Factor Induces Intercellular Adhesion Molecule-1 and Endothelial Nitric Oxide Synthase Expression and Initiates Early Diabetic Retinal Leukocyte... von Joussen, Antonia M., Poulaki, Vassiliki, Qin, Wenying, Kirchhof, Bernd, Mitsiades, Nicholas, Wiegand, Stanley J., Rudge, John, Yancopoulos, George D., Adamis, Anthony P.

Volltext

Erythropoietin Promotes Survival of Retinal Ganglion Cells in DBA/2J Glaucoma Mice von Zhong, Lichun, Bradley, John, Schubert, William, Ahmed, Ednan, Adamis, Anthony P, Shima, David T, Robinson, Gregory S, Ng, Yin-Shan

Volltext

The Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration: Results from the Randomized Phase 2 Ladder Clinical Trial von Campochiaro, Peter A, Marcus, Dennis M, Awh, Carl C, Regillo, Carl, Adamis, Anthony P, Bantseev, Vladimir, Chiang, Yawen, Ehrlich, Jason S, Erickson, Signe, Hanley, William D, Horvath, Joshua, Maass, Katie F, Singh, Natasha, Tang, Fan, Barteselli, Giulio

Volltext

Archway Randomized Phase 3 Trial of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration von Holekamp, Nancy M., Campochiaro, Peter A., Chang, Margaret A., Miller, Daniel, Pieramici, Dante, Adamis, Anthony P., Brittain, Christopher, Evans, Erica, Kaufman, Derrick, Maass, Katie F., Patel, Shienal, Ranade, Shrirang, Singh, Natasha, Barteselli, Giulio, Regillo, Carl

Volltext

Long-term outcomes of ranibizumab therapy for diabetic macular edema: the 36-month results from two phase III trials: RISE and RIDE von Brown, David M, Nguyen, Quan Dong, Marcus, Dennis M, Boyer, David S, Patel, Sunil, Feiner, Leonard, Schlottmann, Patricio G, Rundle, Amy Chen, Zhang, Jiameng, Rubio, Roman G, Adamis, Anthony P, Ehrlich, Jason S, Hopkins, J Jill

Volltext

Insulin-Like Growth Factor-I Plays a Pathogenetic Role in Diabetic Retinopathy von Poulaki, Vassiliki, Joussen, Antonia M., Mitsiades, Nicholas, Mitsiades, Constantine S., Iliaki, Eirini F., Adamis, Anthony P.

Volltext

Vascular Endothelial Growth Factor (VEGF)-Induced Retinal Vascular Permeability Is Mediated by Intercellular Adhesion Molecule-1 (ICAM-1) von Miyamoto, Kazuaki, Khosrof, Samer, Bursell, Sven-Erik, Moromizato, Yasufumi, Aiello, Lloyd Paul, Ogura, Yuichiro, Adamis, Anthony P.

Volltext

Deep Learning Predicts OCT Measures of Diabetic Macular Thickening From Color Fundus Photographs von Arcadu, Filippo, Benmansour, Fethallah, Maunz, Andreas, Michon, John, Haskova, Zdenka, McClintock, Dana, Adamis, Anthony P, Willis, Jeffrey R, Prunotto, Marco

Volltext

Rationale of Basic and Cellular Mechanisms Considered in Updating the Staging System for Diabetic Retinal Disease von Hartnett, M. Elizabeth, Fickweiler, Ward, Adamis, Anthony P., Brownlee, Michael, Das, Arup, Duh, Elia J., Feener, Edward P., King, George, Kowluru, Renu, Luhmann, Ulrich F.O., Storti, Federica, Wykoff, Charles C., Aiello, Lloyd Paul

Volltext

Development of the Port Delivery System with ranibizumab for neovascular age-related macular degeneration von Adamis, Anthony P., de Juan, Eugene

Volltext